Form 8-K - Current report:
SEC Accession No. 0000950170-25-045302
Filing Date
2025-03-26
Accepted
2025-03-26 16:31:05
Documents
13
Period of Report
2025-03-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ivvd-20250322.htm   iXBRL 8-K 61036
2 EX-99.1 ivvd-ex99_1.htm EX-99.1 16833
3 GRAPHIC img59752938_0.jpg GRAPHIC 85687
  Complete submission text file 0000950170-25-045302.txt   327230

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20250322.xsd EX-101.SCH 32075
15 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20250322_htm.xml XML 4874
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 25773696
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)